gold has been researched along with Acinetobacter Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, J; Choi, Y; Joo, M; Kim, JH; Lee, K; Lee, M; Park, J; Shin, E; Yeom, JH | 1 |
| Cao, J; Gong, C; Yang, J; Zhang, N; Zhao, Y; Zuo, J | 1 |
| Javadi, A; Kazemian, H; Kodori, M; Monfared, MRZ; Rad, MR; Rahdar, H; Yazdani, F | 1 |
3 other study(ies) available for gold and Acinetobacter Infections
| Article | Year |
|---|---|
Gold nanoparticle-DNA aptamer-assisted delivery of antimicrobial peptide effectively inhibits Acinetobacter baumannii infection in mice.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Antimicrobial Peptides; Aptamers, Nucleotide; Drug Delivery Systems; Female; Gold; Humans; Metal Nanoparticles; Mice | 2022 |
Hyaluronic acid and antimicrobial peptide-modified gold/silver hybrid nanocages to combat bacterial multidrug resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Gold; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronic Acid; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Particle Size; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Silver; Survival Rate | 2020 |
Antibacterial Activity of Gold Nanoparticles Conjugated by Aminoglycosides Against
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Burns; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gentamicins; Gold; Humans; Metal Nanoparticles; Microbial Sensitivity Tests; Patents as Topic; Wound Infection | 2018 |